论文部分内容阅读
减阻剂是具有减少流体阻力性能的特殊物质,其为平均分子量>106、近似直线结构的血溶性大分子。因具有降低血液流动时的阻力、改善血液循环的作用而被应用到心血管的各个领域。最新的研究表明,减阻剂在改善冠状动脉微循环,改善心肌血流灌注,延缓动脉粥样硬化的形成等方面又取得了一系列新的突破,展现出巨大的临床应用潜力,前景令人鼓舞。
Drag reducing agents are special substances with reduced fluid resistance properties, which are blood-soluble macromolecules with an average linear molecular weight of> 106 and an approximately linear structure. It has been applied to various fields of cardiovascular system because of its resistance to blood flow and improvement of blood circulation. Recent research shows that DRA has made a series of new breakthroughs in improving microcirculation of coronary arteries, improving myocardial perfusion, and retarding the formation of atherosclerosis, showing great potential for clinical application with promising prospects Inspired.